Establishment Labs (NASDAQ:ESTA) (NASDAQ: ESTA) is a medical device company focused on the design, development and manufacture of advanced aesthetic surgical products for the global breast implant market. Founded in 2004 and headquartered in Alajuela, Costa Rica, the company develops proprietary technologies that address both cosmetic and reconstructive needs. Its flagship product line, Motiva Implants, offers a range of smooth-surface and textured implants engineered for natural feel and tissue integration while incorporating safety and performance innovations.
The company’s Motiva Ergonomix and Round SilkSurface implants are manufactured under ISO 13485 quality standards and leverage the proprietary ProgressiveGel Ultima filling material. A key differentiator is the Q Inside Safety Technology, an embedded radiofrequency identification (RFID) microchip that enables non-invasive product tracing and patient-specific information access. Establishment Labs also provides comprehensive surgeon training programs, clinical support services and digital tools to enhance procedural outcomes and post-operative follow-up.
Establishment Labs serves a broad network of plastic surgeons and health care providers across North America, Europe, Latin America and select markets in the Asia-Pacific region. The company has secured multiple regulatory approvals, including US FDA clearance and CE Mark certification, supporting its growth in both established and emerging markets. Manufacturing operations in Costa Rica and strategic partnerships for distribution help ensure supply chain resilience and facilitate expansion into new territories.
Under the leadership of founder and CEO Raúl A. Garcia, Establishment Labs has positioned itself at the forefront of implant innovation through ongoing investment in research and development, collaboration with key opinion leaders and commitment to patient safety. The company’s leadership team combines medical device expertise, regulatory experience and commercial acumen to drive global adoption of its products and reinforce its reputation for quality and innovation in the aesthetic surgery sector.
